Lack of association between endothelial nitric oxide synthase glu298Asp variation, visceral obesity and insulin related phenotypes in Turkish type 2 diabetic patients
Abstract
Keywords
Full Text:
PDFReferences
Tilburg J, Haeften TW, Pearson P, Wijmenga C. Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet. 2001;38(9):569-78.
Morton NE, Lio P. Oligogenic linkage and map integration. In: Pawlowitzki H, Edwards JH, Thompson EA (Eds). Genetic Mapping of Disease Genes, first ed. Academic Press, San Diego, CA 1997. pp 17-21.
Marsden P, Heng H, Scherer S, Stewart R, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478-88.
Hayden MR, Tyagi SC. Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stres. Cardiovasc Diabetol. 2003;2:2.
Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52(5):1270-5.
McNamara DM, Holubkov R, Postava L, Ramani R, Janosko K, Mathier M, et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation. 2003;107(12):1598-602.
Lüscher T, Noll G. Is it all in genes…? Nitric oxide synthase and coronary vasospasm. Circulation. 1999;99(22):2855-7.
Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298 → Asp and T–786 → C polymorphisms. Stroke. 2004;35(6):1305-9.
Yoshimura T, Hisatomi A, Kajihara S, Yasutake T, Ogawa Y, Mizuta T, et al. The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease. J Atheroscler Thromb. 2003;10(1):43-7.
Barroso I, Luan J, Middelberg RPS, Harding AH, Franks PW, Jakes RW, et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol. 2003;1(3):445.
Ukkola O, Erkkila PH, Savolainen MJ, Kesaniemi YA. Lack of association between polymorphism of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Int Med. 2001;249(5):451-9.
Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem. 2003;49(3):389-95.
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva, World Health Organization, 1999.
Arroyo P, Pardio J, Fernandez V, Vargas-Ancona L, Canul G, Loria A. Obesity and cultural environment in the Yucatan region. Nutr Rev. 1999;57(5 Pt 2):S78-82.
Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, et al. Continuous infusion of glucose with model assessment: measurement of insulin and β-cell function in man. Diabetologia. 1985;28(7):401-11.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care. 1999;22(9):1462-70.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science.1988; 239(4839):487-91.
Kahn C. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994; 43(8):1066-84.
Yki-Järvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia. 1995; 38(12):1378-88.
Hales C, Barker D. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;3(7):595-601.
Veldman BA, Spiering W, Doevendans PA, Ver-Voort G, Kroon AA, de Leeuw PW, et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002; 20(10):2023-7.
Hayden MR, Tyagi SC. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. JOP. 2002;3(4):86-108.
Hayden MR, Tyagi SC. Intimal Redox Stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol. 2002;1:3.
Thameem F, Puppala S, Arar NH, Stern MP, Blangero J, Duggirala R, et al. Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans. Diab Vasc Dis Res. 2008;5(2):109-13.
Srivastava K, Biswas UK, Narang R, Varghese JJ, Das N. Prevalence of eNOS Glu298Asp Polymorphism in Healthy Volunteers from a Region of Northern India. Community Genet. 2005;8(3):180-3.
Yoshimura T, Hisatomi A, Kajihara S, Yasutake T, Ogawa Y, Mizuta T, et al. The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease. J Atheroscler Thromb. 2003;10(1):43-7.
Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. AJP-Endocrinology and Metabolism. 1998;274(4 Pt 1): E692-E699.
Kapur S, Bedard S, Marcotte B, Cote CH, Marette A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes. 1997;46(11):1691-700.
Shiuchi T, Cui TX, Wu L, Nakagami H, Takeda- Matsubara Y, Iwai M, et al. ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension. 2002;40(3):329-34.
Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298 → Asp and T–786 → C polymorphisms. Stroke. 2004;35(6):1305-9.
Refbacks
- There are currently no refbacks.